Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Is Thoratec ready for the auction block?
Thoratec Corp. (NSDQ:THOR) may be primed for a buyout by some of the biggest names in the business, according to Oracle Investment Management, which holds about 3 million shares in the heart pump maker.
2. Med-tech stocks rebound after Medicare jolt
Wall Street investors rebounded from the jolt delivered by the Centers for Medicare & Medicaid Services last week, regaining most of the value lost after the agency announced stiffer rules for its coverage of some medical procedures.
1. Olympus probe: Sack “rotten to the core” yes-men
The "yes men" at Olympus Corp. (TYO:7733) who permitted a decades-long scheme to hide billions in losses should all be fired, according to an independent panel’s probe of the affair.
